Inventor · disambiguated record
Bo Hansen
Also filed as: HANSEN BO · HANSEN BO FALCK
2 granted patents·9 pending applications·118 citations·filing 2001–2020
62Inventor score
Files withHANSEN BO2NOVO NORDISK AS2SANTARIS PHARMA AS2ENZON PHARMACEUTICALS INC1HANSEN HENRIK FRYDENLUND1
Top patents by PatentIndex Score
11 records- 0193US7713738B2Oligomeric compounds for the modulation of survivin expressionENZON PHARMACEUTICALS INC·Filed 2004·Granted May 11, 2010·118 cites·9 claims
- 0258US10919949B2Acylated insulin analogues and uses thereofNOVO NORDISK AS·Filed 2018·Granted Feb 16, 2021·0 cites·18 claims
- 0353US2021094999A1Novel Acylated Insulin Analogues and Uses ThereofNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 0449US2004248840A1Oligomeric compounds for the modulation of ras expressionSANTARIS PHARMA AS·Filed 2004·Application pending·0 cites
- 0546US2012088907A1Oligomeric compounds for the modulation of survivin expressionHANSEN BO·Filed 2011·Application pending·0 cites
- 0646US2004241717A1Oligomeric compounds for the modulation of thioredoxin expressionSANTARIS PHARMA AS·Filed 2004·Application pending·0 cites
- 0745US2008188432A1Oligomeric compounds for the modulation ras expressionHANSEN BO·Filed 2006·Application pending·0 cites
- 0843US2003125241A1Therapeutic uses of LNA-modified oligonucleotides in infectious diseasesFiled 2002·Application pending·0 cites
- 0937US2009118213A1Rna antagonist compounds for the inhibition of apo-b100 expressionHANSEN HENRIK FRYDENLUND·Filed 2006·Application pending·0 cites
- 1035US2004210063A1Novel 2,4-diaminothiazole derivativesFiled 2004·Application pending·0 cites
- 1129US2001039275A1Use of 2,4-diaminothiazole derivativesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bo Hansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →